McLain L, Durrani Z, Wisniewski L A, Porta C, Lomonossoff G P, Dimmock N J
Department of Biological Sciences, University of Warwick, Coventry, UK.
Vaccine. 1996 Jun;14(8):799-810. doi: 10.1016/0264-410x(95)00229-t.
A plant virus, cowpea mosaic virus, expressing a 22 amino acid peptide 731-752 of the gp41 glycoprotein of human immunodeficency virus type 1 (HIV-1 IIIB), was shown previously to stimulate HIV-1 cross reactive neutralizing antibodies in adult C57/BL6 mice. Here some parameters concerning the stimulation of HIV-1-specific neutralizing and ELISA antibody have been determined in adult C57/BL6, C3H/He-mg and BALB/c mice. Two injections per mouse of all CPMV-HIV/1 doses tested (100, 10 and 1 microgram chimera which contained, respectively, 1700, 170 and 17 ng HIV peptide per injection) stimulated a strong serum neutralizing antibody response in all mice. One hundred micrograms or 10 micrograms CPMV-HIV/1 per injection gave 99% neutralization of HIV-1 IIIB in C8166 cells at a serum dilution of 1/200, whereas sera from mice immunized with 1 microgram per injection neutralized virus to 97%, 79% and 63% at a 1/200 dilution of serum from C3H/He-mg, C57/BL6 and BALB/c mice, respectively. Restimulation of these mice with the same immunogen dose marginally increased the neutralization titres. The longevity of the neutralizing antibody response increased as the immunogen dose decreased, and was dependent on the strain of mouse, in the order C57/BL6C3H/He-mg BALB/c. Re-immunization with a third injection improved the longevity of the antibody response. All mice immunized with 100 micrograms CPMV-HIV/1 responded with ELISA antibody to the gp41 peptide bound in solid phase. Ten micrograms stimulated ELISA antibody in some but not all mice, while mice immunized with 1 microgram had no detectable ELISA antibody. This synthesis of ELISA antibody decreased > or = 230-fold over the range of immunogen doses tested but, in the same mice, the neutralizing antibody response decreased only twofold, showing an unusual bias to production of the latter. Neutralizing antibodies were thus stimulated at a lower immunogen dose than ELISA antibodies. Antibody which was affinity purified using the free gp41 peptide gave a good ELISA titre but did not neutralize HIV-1, suggesting that the neutralizing antibody is recognizing a conformational epitope on the gp41 oligomer.
一种植物病毒——豇豆花叶病毒,表达了人类免疫缺陷病毒1型(HIV-1 IIIB)糖蛋白gp41的22个氨基酸肽段(731 - 752),先前已证明其能在成年C57/BL6小鼠中刺激产生HIV-1交叉反应性中和抗体。在此,已在成年C57/BL6、C3H/He-mg和BALB/c小鼠中确定了一些与刺激HIV-1特异性中和抗体及ELISA抗体相关的参数。对所有测试的CPMV-HIV/1剂量(100、10和1微克嵌合体,每次注射分别含1700、170和17纳克HIV肽),每只小鼠注射两次,均能在所有小鼠中刺激产生强烈的血清中和抗体反应。每次注射100微克或10微克CPMV-HIV/1,在血清稀释度为1/200时,能使C8166细胞中的HIV-1 IIIB中和率达到99%,而每次注射1微克免疫的小鼠血清,在C3H/He-mg、C57/BL6和BALB/c小鼠血清1/200稀释度下,对病毒的中和率分别为97%、79%和63%。用相同免疫原剂量再次刺激这些小鼠,中和滴度略有增加。中和抗体反应的持续时间随免疫原剂量降低而延长,且取决于小鼠品系,顺序为C57/BL6>C3H/He-mg>BALB/c。第三次注射重新免疫可提高抗体反应的持续时间。所有用100微克CPMV-HIV/1免疫的小鼠对固相结合的gp41肽产生ELISA抗体反应。10微克能在部分但并非所有小鼠中刺激产生ELISA抗体,而用1微克免疫的小鼠未检测到ELISA抗体。在所测试的免疫原剂量范围内,ELISA抗体的合成下降了≥230倍,但在相同小鼠中,中和抗体反应仅下降了两倍,显示出对后者产生的异常偏向。因此,刺激产生中和抗体所需的免疫原剂量低于ELISA抗体。用游离gp41肽亲和纯化的抗体具有良好的ELISA滴度,但不能中和HIV-1,这表明中和抗体识别的是gp41寡聚体上的构象表位。